Jetro gives insight into medical sector
The Indian envoy in Tokyo has invited Japanese investors to participate in the Indian prosperity especially highlighting the potential of collaboration on pharmaceutical and medical devices industry post COVID-19.
Ambassador Sanjay Kumar Verma shared his thoughts on the golden opportunity for India and Japan to further boost relationship in the context of the ongoing COVID-19 crisis.
The Ambassador made the call at a webinar on ‘Medical Devices and API sector: Challenges & Emerging Opportunities’ organized by the Embassy of India, Tokyo in partnership with India’s Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers on 22 May 2020.
Dr. P. D. Vaghela, Secretary, Pharmaceuticals presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India.
He also presented various initiatives taken by the Indian Government to promote trade and business in the country.
Navdeep Rinwa, Joint Secretary, Pharmaceuticals, explained the Department’s schemes to promote manufacturing of bulk drugs and medical devices through Production Linked Incentive schemes and Promotion of Bulk Drug/Medical Devices Parks and requested the delegates to avail benefits of the schemes.
Pharmaceutical Traders Association and Japan Federation of Medical Devices Associations deliberated at the webinar on the Post COVID-19 challenges & opportunities for Pharmaceutical & Medical Device sectors and its impact on the global supply chain and suggested that cooperation between the two countries can contribute to stabilize the supply-chain of especially APIs and Medical Devices.
Representative of JETRO Chennai also shared insights on challenges and emerging opportunities in API sector and Medical Devices.
Representatives of Japanese subsidiaries Nipro India Corp and Eisai Pharmaceuticals India Pvt Ltd shared detailed presentations and their experience about ‘Make in India’ program.
Representatives of major Indian Pharmaceutical and Medical Device Associations presented the future growth opportunities and way forward for Pharmaceutical and Medical Device industry in India.
Finer details were presented by representatives of State Governments of Gujarat, Telangana, Himachal Pradesh and Goa such as package for incentives and taxation benefits, ease of doing business initiatives, land availability, infrastructural facilities, regulatory framework and invited Japanese companies for investing in their respective States.
The webinar saw participation by representatives of Andhra Pradesh MedTech Zone, Wockhardt, Sun Pharma, Panacea Biotec and other large number of Japanese companie. They also participated in G2B and B2B networking at the webinar. fiinews.com
